Monday, June 26, 2017

Trump Signs VA Reform Bill

Barnini Chakraborty, in a June 23, 2017 Fox News post, reports:
President Trump on Friday signed Veterans Affairs reform legislation meant to protect whistleblowers while making it easier to fire problematic employees at the department... The Department of Veterans Affairs Accountability and Whistleblower Protection Act passed by Congress earlier this month streamlines the process to remove, demote, or suspend VA employees for poor performance or misconduct. In addition, it authorizes the VA secretary to recoup any bonuses awarded to employees who have acted improperly.
The bill enjoyed broad bi-partisan support and fulfilled a Trump campaign promise. The ongoing VA debacle is a cautionary tale for proponents of a single payer system.

Read more in the current issue of Week in Review>> http://conta.cc/2tbdS0u

Monday, June 12, 2017

FDA Approves First Generic Truvada in U.S.

Robert Lowes delivers news from the FDA on June 09, 2017:
    
The U.S. Food and Drug Administration (FDA) has approved the first generic version of emtricitabine/tenofovir disoproxil (Truvada, Gilead Sciences) to both treat and prevent HIV infections in this country, the agency announced today.
     
The list price for Gilead Science's Truvada is roughly $1500 for a month's regimen of one pill per day, or about $18,000 a year, although health insurance and patient-assistance programs knock down the price considerably. Generic versions of Truvada in other countries cost as little as $70 a year, according to Mitchell Warren, executive director of AVAC, an international organization that promotes HIV prevention.

Read more in the current issue of Week in Review>> http://conta.cc/2tdyFgW